SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IVAX Insider Trading -- Ignore unavailable to you. Want to Upgrade?


To: Doug who wrote (183)11/18/1997 12:58:00 PM
From: 5,17,37,5,101,...  Respond to of 756
 
Looks like the market doesn't much care for this restructuring. Ivax is down 1/2 as of this moment since the announcement. I believe the market is expecting perpetual write downs and asset sales to fund an organization that can produce no earnings. A sale of the company is in order to a company that can profitably integrate it. I recommend selling your shares if you have any on the Paxene FDA approval (if it ever happens).
Wrong on this one,
Jackson